Researchers at Moffitt Cancer Center have developed a new way to predict how cancer cells evolve by gaining and losing whole ...

Researchers at Moffitt Cancer Center have developed a new way to predict how cancer cells evolve by gaining and losing whole ...

Researchers at Moffitt Cancer Center have developed a new way to predict how cancer cells evolve by gaining and losing whole chromosomes, changes that help tumors grow, adapt and resist treatment. In ...

Prostate cancer often earns the label “silent killer” because it can develop and progress for years without producing noticeable symptoms. Understanding this timeline becomes crucial for men seeking ...

Scientists have developed a tool that can predict how bowel cancer adapts to treatment – helping researchers to design new personalized drugs that will keep patients living well for longer. A team ...

TAMPA, Fla. (Sept. 8, 2025) — Researchers at Moffitt Cancer Center have created the first genetically engineered model of lung cancer in naked mole rats, a species long thought to be resistant to ...

New research from Memorial Sloan Kettering Cancer Center (MSK) finds a potential therapeutic opportunity in regulatory T cells’ resilience to the loss of Foxp3; shows how cancer develops resistance to ...

Liver cancer is a lethal disease with limited treatment options for advanced stages. While risk factors such as viral hepatitis, alcohol use, and obesity increase the likelihood of hepatocellular ...

The call comes as new analysis by Cancer Research UK suggests that clothing choices may influence where skin cancer develops.** The latest data (from 2018-2021) shows that, across the UK, 40% of ...

Researchers found that pancreatic pre-cancer cells mimic dementia by forming clumps of proteins due to faulty recycling processes. These insights could shed light on why pancreatic cancer develops so ...

Radon and smoking are both known causes of lung cancer, but when someone is exposed to both, the results can be deadly.

Scientists have now developed a DNA blood test that can predict how well patients with breast cancer will respond to ...